The human immunodeficiency virus type 1 (HIV-1) negative factor, or Nef, has a variety of functions that are important in viral pathogenesis. Sequence analysis has identified nef mutations that are linked to the rate of disease progression in adults and children infected with HIV-1 subtype B. Here we have sequenced and analyzed HIV-1 subtype C nef sequences from 34 children with rapid (RP) or slow progressing (SP) disease and identified polymorphisms associated with disease stage including motifs involved in specific pathogenic functions. Unlike subtype B, insertions and deletions in the N-terminal variable region were observed exclusively in SP children (8 out of 25). Strong positive selection pressures were found in sites of known functional importance among SP sequences, whereas RP had strong negative selection across the gene. A lineage analysis of selection pressures indicated weaker pressure across the nef gene in SP sequences bearing a deletion in region 8-12, suggesting this deletion has functional importance in vivo. Together these results suggest a differential adaptation of certain Nef functions related to disease progression, some of which may be attributable to immune-imposed pressures. These data broadly reflect previous studies on subtype B, corroborate the decreased cytopathicity of SP viruses, but also highlight potential subtype differences that require further investigation.
INTRODUCTION

A
LTHOUGH CHILDREN INFECTED WITH HIV-1 tend to progress more rapidly to AIDS than adults, 1,2 the distribution of disease outcome is bimodal. In the developed world approximately 20% of children progress to AIDS within the first few years (rapid progressors or RP), while the remaining children survive 5 or more years with asymptomatic infection (slow progressors or SP). 3, 4 However, in sub-Saharan Africa where the majority of the world's HIV infected population live, up to 50% of pediatric cases are RP. 5 RP infants tend to show very poor immune responses against the virus, and hence little or no control of viremia. 6 Conversely, slow disease progression is associated with the emergence of stronger immune responses, notably of cytotoxic T lymphocytes (CTLs), which are the major determinants of viral control. 1, [7] [8] [9] [10] However, it has also been noted that some slow or nonprogressing patients harbor circulating HIV-1 variants with reduced infectivity in vitro, [11] [12] [13] and the presence of deletions or unusual mutations associated with reduced pathogenesis suggests a role for viral attenuation in disease progression.
The nef (negative factor) gene encodes a small membraneassociated protein that has interactions with multiple cellular proteins and can lead to enhancement of viral replication and immune evasion. 14 Nef is essential to pathogenesis as shown by studies in animal models 15, 16 and in nonprogressing patients infected with nef-defective viruses. [17] [18] [19] [20] [21] Although large deletions are rare, including viruses from African children, 22 discrete polymorphisms linked to progression rate are more common, 8, [23] [24] [25] and may affect a variety of Nef functions. 25, 26 The functions of Nef include CD4 downregulation 27 by endocytosis and lysosomal degradation 28 ; downregulation of cell surface MHC-1, 29, 30 which reduces the recognition and targeting of infected cells by CTLs 31, 32 ; enhancement of replication 33, 34 ; interaction with cell signaling pathways; 14 and enhancement of the production of chemokines by infected cells, which regulate cellular activation. 35 Although there is a strong pressure for the maintenance of Nef function in vivo, largely due to MHC-1 downregulation and its assistance in immune evasion, 36 unusual mutations and deletions in N-and C-terminal domains are common in slow and nonprogressing individuals. 17, 18, 21, 23, 25, 26, 37, 38 The Nef protein is strongly targeted by the immune system and notably includes highly immunodominant CTL epitopes. [39] [40] [41] While pathogenic properties are mainly attributable to the hydrophilic N-and C-terminal domains, 42 clusters of CTL epitopes tend to fall in the central hydrophobic region of the gene, 43, 44 therefore CTL escape mutations may be less likely to disrupt pathogenic functions. However, some escape mutations have been linked to a decrease in specific pathogenic functions such as defective MHC-1 and CD4 downregulation, 20, 45 and are associated with strong CTL responses in vivo 46 and in vitro. 32 It is therefore possible that certain HLA types, which target the hydrophilic N-and C-terminal regions of the protein, drive the emergence of nef mutations that disrupt pathogenic functions.
The bimodal nature of disease progression in pediatric HIV provides an ideal context in which to explore nef variation and the potential functional differences in different host environments. In this study we provide HIV-1 subtype C nef genes from 34 pediatric patients with differing rates of disease progression and compared these to similar cohorts infected with HIV-1 subtype B viruses. In contrast to other recent reports from African pediatric patients 22 we find evidence for nef gene defects associated with nonprogressive infection in subtype Cinfected children and identify polymorphisms within the hydrophilic regions that may impact certain Nef functions and hence curtail pathogenesis.
MATERIALS AND METHODS
Patients and samples
Samples used in this study were obtained from 34 antiretroviral-naive perinatally infected children attending clinics in Johannesburg between 1999 and 2002. Slow progressing infants (TM prefix) samples were obtained from HIV-1-infected children between the ages of 4 and 10 years who had remained either asymptomatic or mildly symptomatic until sampling. Rapid progressing infants were defined as those from 2 to 25 months of birth who were classified as clinical category C under the CDC (Centers for Disease Control) definition of AIDS (RP and COT prefix). Viral isolates were generated from patient peripheral blood mononuclear cells (PBMCs) using standard coculture techniques in donor PBMCs, and were of low passage number (maximum 2), as described elsewhere. 47 
PCR and sequencing
Viral RNA was extracted from patient plasma (n ϭ 18) or primary isolates (n ϭ 16) using the Roche MagNA Pure Total Nucleic Acid Isolation kit with the MagNA Pure LC instrument (Roche Diagnostics GmbH, Nonnewald, Penzburg, Germany). Polymerase chain reactions (PCR) were carried out using subtype C-specific primer pairs and cycling conditions previously described (HXB2: 8785-9414). 48 First round amplification was done using Roche Expand High Fidelity Taq Polymerase and included 10ϫ buffer (Roche Applied Bioscience, Nonnenwald, Penzburg, Germany). All second round PCR products were cleaned prior to sequencing using the High Pure PCR Product Purification Kit (Roche), according to the standard protocol. Amplicons were sequenced using the ABI Big Dye terminator system (version 3.1) according to the manufacturer's instructions (Applied Biosystems, Foster City, CA), using 4 l of ready reaction mix, 2 l of 5ϫ sequencing buffer, and 4 pmol of each inner primer, plus 6 l of ddH 2 O. Terminator reactions were then carried out with 25 cycles of 96°C for 10 sec, 50°C for 5 sec, and 60°C for 4 min. Sequencing reaction products were cleaned using sodium acetate precipitation, where 20 l of reaction product is added to 50 l of EtOH/NaAc mix, precipitated at 2000 ϫ g for 30 min, washed once in cold 70% EtOH, and dried by vacuum centrifuge, and run on an ABI 3100 automated sequencer. Sequence data were edited with the Sequencing Analysis 3.3 program (Applied Biosystems), and assembled using Sequencher 4.1 (Genecodes, Ann Arbor, MI). GenBank accession numbers for these sequences are DQ398972-DQ399005.
Additional sequences
All available full-length subtype C (n ϭ 205) and subtype B (n ϭ 192) nef sequences were downloaded from the Los Alamos sequence database (http://hiv-web.lanl.gov) and aligned against the HXB2 reference strain. Single sequences were used from each patient and for those with multiple sequences a consensus sequence was generated. The subtype B data set included 33 RPs defined as adults who developed AIDS within 5 years 23, 25, 37, 49 and infants progressing to AIDS within 2 years of infection. 18, 20 Individuals who had all survived with HIV-1 infection for 10 years or more were classified as SPs or nonprogressors (n ϭ 88). 17, [23] [24] [25] 37, 38 All sequences were subtyped using the REGA HIV-1 Automated Subtyping Tool (http://www.bioafrica.net/ subtypetool/html). 50 
Sequence analysis
All sequences generated in this study were aligned manually using Se-Al (http://evolve.zoo.ox.a.uk/software). Amino acid polymorphisms that were novel or occurred at less than 5% frequency in the subtype C population, as well as deletions and insertions (indels), were identified by comparison with the 205 subtype C sequences from Los Alamos and HXB2 numbered. Among these, polymorphisms that may be associated with disease progression were considered to be those that occurred more than once in either the SP or RP cohort but not both, and were not clustered phylogenetically. For the analysis of selection pressures, sequence regions that could not be aligned with certainty, including all insertions and deletions, were removed before estimating phylogenies using the PAUP package. 51 Phylogenetic trees were estimated using the GTR ϩ I ϩ ⌫ 4 model of nucleotide substitution as this gave consistently better likelihoods than the codon positions model for HIV-1 (data not shown). Maximum likelihood (ML) trees were estimated under this model using TBR branch swapping. The breadth and strength of selection pressures were estimated for all sequence data under an ML framework (CODEML program 52, 53 ), which employs a codon-based approach to estimate rates of nonsynonymous to synonymous () substitutions per site under two nested models with a beta distribution of among sites: M7 (neutral) and M8 (selection). 53 We applied more conservative criteria to reduce the risk of type I errors associated with detecting positive selection in small data sets. These were a significant M7/M8 likelihood ratio test, an value greater than 2, and a Bayesian posterior probability of p Ͼ 0.95 as significant evidence for positive selection. Negatively selected sites (those under strong purifying selection) were considered to be those with less than 0.2 and neutral sites those with between 0.8 and 1.2. A lineagebased approach was used to compare selection pressures in RP and SP terminal and internal branches, as well as branches carrying deletions in the region 8-12 (which is associated with disease progression in this data set). In this case we applied the M0 model of selection, which averages among sites, and compared five nested models for among lineages using a likelihood ratio test. 54 
RESULTS
We sequenced full-length HIV-1 subtype C nef genes from antiretroviral naive infants and children with varying rates of disease progression. Among rapid progressing infants (COT and RP prefix, n ϭ 9) the median age of sampling was 0.5 years, and all infants had severe symptoms of AIDS defined as clinical category C. Slow progressing children (TM prefix, n ϭ 25) had a median age at sampling of 6.7 years and all had either asymptomatic or moderately symptomatic infection. Clinical and virological data for this cohort are summarized in Table 1 and described elsewhere. 47 All 34 nef genes amplified successfully and, with the exception of TM20, were sequenced across the full gene length. Although TM20 amplified, the first 96 nucleotides could not be sequenced unambiguously. All sequences were confirmed as subtype C using the REGA HIV-1 Automated Subtyping Tool. 50 Figure 1 shows the full amino acid alignment, annotated with functional information from the Los Alamos database and the HIV-1 proteomics resource (www.bioafrica.net/ proteomics 55 ). Comparison to the consensus C sequence from the Los Alamos database revealed that more variation occurred in the N-terminal and C-terminal ends of the protein, and fewer in the central conserved region spanning HXB2 positions 60-140.
Sequence differences relating to disease progression
To identify polymorphisms that might be associated with the disease progression state, sequences from RP and SP were screened for mutations with a prevalence of less than 5% in the subtype C population and which occurred more than once in either the SP or RP cohort but not both. Additionally, we considered only polymorphisms occurring de novo in individuals and therefore occurring independently in two or more branches of the tree (Fig. 2) . These polymorphisms were numbered according to HXB2 and expressed as changes from the subtype C consensus and listed in Table 1 .
Although we identified polymorphisms in both SP and RP isolate sequences, more were found among SP sequences (total ϭ 17) than RP sequences (total ϭ 2). The sites at which they occurred were clustered within the N-and C-terminal regions of the protein. Those that occurred at sites of high conservation (where 90% or more published subtype C sequences have a single amino acid identity at this site), and hence that may indicate functional or structural constraints, are marked in bold type in Table 1 . Of additional interest are amino acid substitutions that involve a change in the properties at that site (e.g., polar/nonpolar or positively/negatively charged) and that are marked in italics on Table 1 . Among the 17 SP-specific polymorphisms, 8 occurred at conserved sites, of which 5 involved no changes in the charge or polarity of the site (L43F, E63D, V114I, N126C, and E201D), indicating that in spite of strong pressure to change identity, they are subject to major structural or functional constraints. In comparison, 6/9 variable site polymorphisms involved changes in polarity or charge. All SP-and RP-specific polymorphisms are marked in bold in the alignment ( Fig. 1 ) and on the branches of the tree at which they occur in Fig. 2 . Although not identified in the screening method applied, we also noted that the mutation G3N in the N-myristoylation motif was found in 5/25 SP sequences compared to 0/9 RP sequences. However, there were no mutations in either cohort that would disrupt either myristolyation of the protein (MGxxxS, positions 1-6) or the protease cleavage motif CAW / LEA (positions 55-60).
We observed significant length variation in SP sequences attributable to insertions and deletions in the N-terminal domain. Out of 25 SP nef sequences 8 had deletions in the N-terminal region 8-12 (shown in Table 1 ) compared to none of the 9 RP infant sequences. Additionally, 3 SP sequences had an insertion in the variable duplication region 24-35 compared to none of the RP sequences. Also of note was that within the acidic region 62-65 (EEEE), the consensus for subtype C nef sequences included an additional glutamic acid residue (IN65) present at 92% frequency in the subtype C population. Among the SP studied, 7/25 had lost this insertion and an additional 5 had a mutation at this site, compared to only 1/9 RP sequences. Table 2 shows the indels we identified in this cohort and estimates of their frequency in previously published HIV-1C and HIV-1B sequences. Additionally we have compared the frequency of these mutations in HIV-1B nonprogressors and slow progressors (NP/SP; n ϭ 88, 71 adults and 7 children) and rapid progressors (RP; n ϭ 33, 27 adults and 6 infants) using combined data from multiple studies. 17, 18, [23] [24] [25] 37, 38 Deletions in the region 8-12 were of low frequency among subtype C sequences from the database (9.3%) but were found exclusively among
WALKER ET AL. 206
8/25 (32%) SP sequences in our cohort (Table 2) . However, within subtype B sequences these deletions were more common (16.1%) but did not show a higher frequency among SPs in either adult or pediatric infections. Insertions between positions 24 and 25, found in 2/25 (8%) of our SP sequences, were at a slightly higher frequency among subtype B sequences (14.8%) than in subtype C (9.3%). These insertions were not exclusive to the SP/NP group in subtype B sequences but were at a correspondingly higher frequency (39.8% compared to 24.4% in RPs). As expected, the subtype C-specific insertion at position 65 was less common in subtype B sequences but was also lower among subtype B SP, similar to our cohorts. These indels have been marked on a maximum likelihood phylogenetic tree (Fig.  2) to identify whether the deletion may be a phylogenetically clustered rather than evolving de novo in each case. Consistent with previous studies on disease progression, our analysis showed that the different disease progression groups did not form distinct phylogenetic clusters on the tree (Fig. 2) . Furthermore, we observed limited clustering of deletion-bearing variants, suggesting that deletions were likely to occur de novo during disease progression within a patient. Similarly, we found evidence that this deletion was more frequently transmitted as evidence by phylogenetic clustering in subtype B at the population level (data not shown). IN PAEDIATRIC HIV-1-C INFECTION 207 a Clinical category is based on the CDC 1994 revised HIV Pediatric Classification System: N, asymptomatic; A, mildly symptomatic; B, Moderately symptomatic; C, severely symptomatic; na, not available; **short sequence of TM20.
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b Putative disease progression-associated polymorphisms, defined as those at a prevalence of less than 5% in the subtype C population, occurred more than once in either the SP or RP cohort but not both, and do not cluster phylogenetically. Sites are HXB2 numbered but amino acid changes are compared to the subtype C consensus. Mutations occurring at sites of high conservation (Ͼ90% amino acid identity in subtype C) are in bold. Mutations involving changes in amino acid properties are in italics.
Analysis of nonsynonymous and synonymous substitution ratios
To determine the evolutionary processes that have shaped nef diversity we carried out an analysis of selection pressures using a maximum likelihood framework. 54 Strikingly, our analysis revealed the existence of positive selection only in the SP sequences ( Table 3 ). The RP sequences showed relatively weak positive selection (p ϭ 0.009), where the maximum [needchar] was 1.73, and which falls below our arbitrary cut-off of Ͼ 2, as clear evidence for positive selection. In contrast, the for the SP was 3.04 and was highly significant (p Ͻ 0.0001). This result was confirmed using the single likelihood ancestor counting (SLAC) method applied in the Datamonkey online tool (www.datamonkey.org 56 ). In this case the results suggest both a broader and a stronger immune selective pressure on the nef gene within SP individuals (data not shown). In particular, a greater proportion of sites fell into the negatively selected category in RP suggesting high structural conservation, whereas among SP these sites fall into the neutral or positively selected categories (Table 3) . These positively selected sites are shaded in Fig. 1 , including 5 sites with strong support ( Ͼ 2, p Ͼ 0.95) and 7 sites with weaker support ( Ͼ 2, p Ͼ 0.9). Interestingly, these selected sites are also clustered in the terminal portions of the protein. Of the disease progression-associated mutations, four of these were also under positive selection in this cohort (positions 11, 49, 54, and 156). Using our phylogenetic tree we then tested the hypothesis that different terminal branches have different selection pressures. As shown in Table 4 , internal branches had significantly higher than terminal branches, indicative of positive selection driving amino acid changes to fixation (A/B: p Ͻ 0.05). Allowing for different among SP and RP (model C) did not improve likelihood to model B, which had a single for terminal branches (p ϭ 0.45). However, when sequences bearing a deletion in the region 8-12 were grouped separately (models D and E) the was lower among deletion-bearing sequences, which did improve the likelihood and which exhibited borderline significance (⌬ ϭ 0.32, N ϭ 0.43: p ϭ 0.06). However, SP sequences without the deletion had no difference in from RPs (0.43 and 0.44, respectively). This analysis was repeated for a collection of sequences from subtype B of known rate of disease progression (Table 4 ). In this data set sequences with deletions existed among both rapid and slow progressing patients. Consistent with our findings for subtype C, RP and SP terminal branches were subject to the same selection pressures, but deletion-bearing sequences had lower selection pressure (model D) and resulted in a better likelihood. This finding supports a role for the deletion in escape from immune pressure,
WALKER ET AL. 208
FIG. 1. HIV-1C
nef sequences from rapid (COT and RP prefix) infants and slow progressing children (TM prefix), aligned to the subtype C consensus sequence from Los Alamos and HXB2 numbered, showing important functional regions. Unusual polymorphisms that occurred more than once in either the SP or RP cohort but not both, and occurred at less than 5% of previously published subtype C sequences, are in bold. Positively selected sites are shaded, including (dark gray) sites with strong support ( Ͼ 2, p Ͼ 0.95) and (light gray) sites with weaker support ( Ͼ 2, p Ͼ 0.9). Indels are boxed.
suggested by its association with SP subtype C-infected children, and may suggest a previously uncharacterized in vivo role for this motif.
DISCUSSION
In this study we have sequenced HIV-1 subtype C nef genes from pediatric patients who experienced different disease outcomes. We have identified length variations and amino acid polymorphisms exclusive to RP and SP cohorts. We found no large deletions or premature stop codons that have previously been associated with long-term nonprogression, [17] [18] [19] [20] [21] but, similar to many subtype B studies, we found a number of discrete polymorphisms specific to slow progressors. 8, [23] [24] [25] These polymorphisms clustered in the N-terminal and C-terminal (hydrophilic) region of the protein, some of which corresponded to motifs identified as being involved in the pathogenic functions of Nef. Previous studies have also shown mutations in these motifs decrease the pathogenic functions of Nef in SP and NP patients of both children 20, 45 and adults. 17, 57 There are two important sites involved in protein modification in Nef: the myristoylation signal MGxxxS and the protease cleavage motif CAW/LEA. The myristolyation signal was intact in both RP and SP sequences in our study, which is vital for both CD4 and MHC-1 downregulation. 58 However, 5/25 (25%) SP sequences carried the mutation G3N not found among RP, which may indicate an association with slow progression, but its impact on Nef localization is yet to be determined. The protease cleavage motif was also conserved in both cohorts. Therefore any differences in pathogenic Nef function that might exist between these two cohorts are unlikely to be attributable to protein modification.
An important pathogenic function of Nef is the downregulation of cell surface expression of CD4, the primary entry receptor for HIV, 27 which increases infection rates by reducing superinfection, 59 promoting Env incorporation, 60 and enhancing the release of viral progeny. 61 The Nef binding site for CD4 comprises amino acids C55-Q61 (CAWLEAQ motif), G95, G96, L97 (GGL motif), R106, and L110. 63 Although defects in CD4 downregulation are linked to slow disease progression in adults, 45 this function may be enhanced after the onset of AIDS due to selection for rapidly replicating variants. 64 Motifs involved in CD4 downregulation were well conserved among all the RP and SP sequences, which might reflect the onset of immunodeficiency in SP patients at the time of sampling. IN PAEDIATRIC HIV-1-C INFECTION  209 
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FIG. 1. (Continued).
MHC-1 downregulation by Nef reduces the ability of CTLs to recognize and destroy infected cells, 30, 31 and involves molecular determinants different from CD4 downregulation. 27 There are four distinct motifs, including the myristoylation signal, 58 an acidic region 63-66 (EEEE), 65 the PxxP 3 motif in the core domain (PVTPQVPLRP 69-78), 65, 66 and a helix near the N-terminus of the protein at sites 22-24. 66 Among our sequences the acidic region motif EEEE, which also binds to the PACS-1 protein, was variable in both cohorts, although the E63D mutation was SP specific. Although D and E are simi-WALKER ET AL. 210   FIG. 2 . nef sequence ML tree. Putative disease progression-associated polymorphisms (described in Tables 1 and 2 ) are written above the branches, and indels are marked on the branch on which they occur. The different deletions are shaded according to the key. larly charged amino acids, this variant is rare among subtype C database sequences. We also found higher variation in RP sequences at positions 64 and 65; although these polymorphisms were neither RP specific nor under selection, we suggest this neutral variation may have accumulated due to low pressure to conserve this function in patients with little or no viraemic control. The insertion of an additional glutamic acid residue at position 65 (IN65), which is highly conserved in subtype C (Ͼ90%), was less common in SP than RP sequences. The N-terminal variable helix (positions 17-26) had high diversity and three sites under positive selection in the SP sequences, including 22 and 24, which are essential for efficient MHC-1 downregulation. 64 In summary, we found evidence for adaptation within MHC-1 downregulation motifs that may reflect a decreased efficiency of this function in SPs. Although there is strong pressure to maintain Nef function in vivo, during immunodeficiency this function may be less strictly conserved, whereas replication enhancement and CD4 downregulation are maintained. 64 Although CD4 and MHC-1 downregulation are two of the key functions of Nef in vivo, it also interacts with numerous cellular proteins involved in trafficking and signaling pathways. 14, 67 Activation of the p21-activated kinases (PAK) elicits a signal transduction cascade essential for T cell activation, 68 involving RRTE at positions 21-24, 105, and 106, 68,69 although we found no SP-specific mutations at these sites. Both groups were conserved in the polyproline helix clusters (PxxP) 3 and SH3 binding domains involved in the recruitment of Src kinases Hck and Vav. 67, 70 In the adaptor protein (AP1, 2, 3) recruitment site at positions 160-165 (ExxxLL), SP had polymorphisms at 162 that occurred at ϳ6% in subtype C sequences. The PKC and the COP binding sites were conserved in both cohorts, but A83G was more commonly found in SPs (14/25 SP; 1/9 RP). Interestingly there were SP-associated polymorphisms downstream of the COP-binding site (EVEE): A156D and G159R, and both sites 151 and 156 were under positive selection. This may indicate alterations to the availability of this motif to ␤-COP molecules, 71, 72 hence a reduced ability of Nef to cause lysosomal degradation of CD4. 72 Finally, mutations in motif 204-205 (KD in HIV-1C) have been shown to decrease the uptake of Nef protein into cells, 73 and D205N was present more frequently in SP sequences.
The most apparent difference between cohorts was in the N-terminal domain positions 2-57, which anchor the protein to the membrane of infected cells. 67 Within this region SP sequences had 8 specific polymorphisms (bolded in Fig. 1) , and 8 sites under positive selection (highlighted in gray in Fig. 1 ) (3 were both), as well as indels. Deletions, specific polymorphisms, and positive selection occurred in SPs at sites 8-12, which lie within the ␣ 1 -helix. 74, 75 Among similar cohorts of HIV-1B these deletions were found in roughly equal proportions in both RP and SP/NP patients. 18, 20, [23] [24] [25] 37, 38 It has previously been suggested that the 8 amino acid stretch following the myristoylation signal is highly variable, shows an apparent lack of selection, and is thought to serve as a IN PAEDIATRIC HIV-1-C INFECTION 211 flexible spacer region on the external surface. 76 Although highly speculative, our data indicated that sequences carrying deletions might be subject to weaker selection pressure than other SP sequences, even when region 8-12 was removed from the alignment. Hence deletions in this region appear to relate to viral control in subtype C, perhaps only in pediatric patients, which needs to be resolved as more sequences from HIV-1 subtype C patients of a known disease progression stage become available. Among published epitopes from HIV-1B infections there is a low prevalence of CTL epitopes spanning this region, 77 whereas a large scale study on subtype C infections found a relatively common CTL epitope spanning this region (CSIVGWPAIR-ERMMR), 78 which may explain the relationship of deletions within this epitope with slow progression in subtype C, and therefore lower selection pressures reflect escape from immune control. Phylogenetic studies typically find a higher genetic divergence and bias toward nonsynonymous substitutions in slow and nonprogressing children, 79 associated with stronger specific immune responses. 80 However, the evolution of the nef gene among rapid and slow progressing adults may differ from that of other genes as high genetic divergence is not exclusively found in SPs 17, 18 and a high rate of positive selection is also correlated with the rate of viral replication. 18 For example, it has been shown that true NPs have a lower evolutionary rate compared to both SPs and RPs due to a lower replicative rate. 18, 64 Our selection analysis revealed positive selection in SP sequences, reflecting immune pressures in the context of ongoing replication. Correspondingly, we found a broad negative selection on RP sequences, perhaps implying convergent evolution similar to that found in adults during the seronegative period. 81, 82 In summary, we provide evidence to suggest relaxation of constraints on Nef function and structure in slow progressing infections, and that this is at least partially driven by adaptive evolution likely due to escape from specific CTL responses during chronic infection. We have also identified some potentially important differences between subtype B and C that need to be investigated further, perhaps with in vitro mutagenesis experiments to characterize their impacts on Nef function. The SPassociated polymorphisms we have identified in Nef from SP children accumulated during the course of infection are likely to decrease MHC-1 downregulation and other cell signaling functions, but CD4 downregulation appeared to be more conserved, and may reflect that some children in this cohort had begun to develop immunodeficiency. By comparison, RP infants showed little evidence of adaptive change and functional conservation in the Nef gene. Our data support a model of differential optimization of certain Nef functions as an adaptation to the distinct immunological environments characteristic of pediatric HIV infection. 
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